Macrophage Dysfunction in Autoimmune Rheumatic Diseases and Atherosclerosis

Area of Science:

• Immunology
• Rheumatology
• Cardiology

Background:

• Cardiovascular pathology from atherosclerotic lesions is a significant issue in patients with autoimmune rheumatic diseases (ARDs).
• Chronic low-grade inflammation, driven by uncontrolled innate and acquired immunity, is implicated in both ARDs and atherosclerosis.
• Immune cells, particularly macrophage monocytes, are crucial in the immunopathogenesis of both conditions.

Purpose of the Study:

• To investigate the role of activated monocyte/macrophages in the pathogenesis of autoimmune and atherosclerotic inflammation.
• To deepen the understanding of chronic inflammation mechanisms in the context of ARDs and atherosclerosis.

Main Methods:

• The study focuses on the immunopathogenesis of ARDs and atherosclerosis.
• It examines the role of macrophage monocytes, specifically the balance between M1-like and M2-like subtypes.
• The research delves into the mechanisms of chronic inflammation in these conditions.

Main Results:

• An imbalance in M1-like and M2-like macrophages is identified as a potential cause of ARDs.
• Activated monocyte/macrophages are highlighted as a key pathogenetic factor in both autoimmune and atherosclerotic inflammation.
• The study underscores the fundamental role of chronic inflammation in all stages of ARDs and atherosclerotic processes.

Conclusions:

• Understanding the role of activated monocyte/macrophages is crucial for advancing knowledge in chronic inflammation pathogenesis.
• Targeting macrophage polarization may offer therapeutic strategies for managing cardiovascular risks in ARD patients.
• The shared inflammatory pathways in ARDs and atherosclerosis present opportunities for integrated treatment approaches.